NCT02262078View on ClinicalTrials.gov

Inhaled Sodium Nitrite on Heart Failure With Preserved Ejection Fraction

PHASE2CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Heart Failure
Interventions
DRUG

Sodium Nitrite Inhalation Solution

90mg of (nebulized) inhaled sodium nitrite will be administered (by inhalation) to participants prior to exercise.

OTHER

Placebo

Normal saline will be administered (by inhalation) to participants prior to exercise.

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

Aires Pharmaceuticals, Inc.

INDUSTRY

collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Mayo Clinic

OTHER